Hemorrhage irrigation reduces need for repeat operations in the most common neurosurgery emergency procedure
According to a study published in The Lancet, irrigation during a craniostomy for a chronic subdural hemorrhage is worthwhile. The randomized comparative trial of five centers is historic in the field of neurosurgery in Finland.
The Finnish study of intraoperative irrigation versus drain alone after evacuation of chronic subdural haematoma (FINISH) investigated whether it is worthwhile to irrigate a chronic subdural hematoma during surgery
Half the patients had their hemorrhage irrigated and half did not. Otherwise, the procedure was carried out in the same way. The main result was that there was significantly less need for repeat procedures in patients who had their hemorrhage irrigated during surgery. Patients’ functional capacity and mortality did not differ between the groups.
The research project involved all Finnish neurosurgery units from the university hospitals of Helsinki, Kuopio, Tampere, Turku, and Oulu. A total of 589 patients with symptomatic chronic subdural hematoma were included in the study.
“Based on the results, we recommend that surgery be performed with irrigation as has been the current treatment protocol in Finland. The role of irrigation in surgery has not been previously studied in a randomized setting and the methods of intervention vary worldwide”, says Co-principal Investigator and Associate Professor Rahul Raj from HUS Neurocenter.
Chronic subdural hematoma requires neurosurgical treatment in the emergency department
Chronic subdural hematoma is the most common condition requiring neurosurgical treatment in the emergency department. Its symptoms may include difficulty walking, loss of strength, speech impediment, memory problems, headaches or epileptic seizures. Without treatment, a hematoma can be fatal. In a trephine craniostomy, a small hole is drilled in the skull and the clot is removed either by irrigating and then inserting a drain or by simply inserting a drain.
Co-principal investigator, Pihla Tommiska, MD, adds that trepanation is one of the most common neurosurgical procedures and the number of operations has increased dramatically in Finland in recent decades.
The study is historic in the field of neurosurgery, as a national randomized comparative study of five centers has never been conducted in Finland before.
The study was designed and implemented in collaboration with the Finnish Centre for Evidence-Based Orthopaedics (FICEBO) research group at the University of Helsinki and HUS. The group is internationally renowned for its randomized comparative studies
”When Rahul Raj, Pihla Tommiska and Kimmo Lönnrot presented their research idea in 2019, it was immediately clear to us that FICEBO would be putting its expertise and resources at the disposal of a great idea and ambitious young researchers. Our hope is that FINISH research can encourage young researchers to do more sustained research work," say Professor Teppo Järvinen and Research Director, Associate Professor Simo Taimela.
The study was published in The Lancet journal on June 6, 2024
Reference:
Raj R*, Tommiska P*, Koivisto T, Leinonen V, Danner N, Posti JP, Laukka D, Luoto TM, Rauhala M, Tetri S, Korhonen TK, Satopää J, Kivisaari R, Luostarinen T, Schwartz C, Czuba T, Taimela S, Lönnrot K*, Järvinen TLN* on behalf of the Finnish study of intraoperative irrigation versus drain alone after evacuation of CSDH (FINISH) study group. Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial. The Lancet 2024; 6 June
Link to the publication: https://doi.org/10.1016/S0140-6736(24)00686-X
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Keywords
Contacts
Rahul Raj, Associate Professor, Specialist in Neurosurgery
Email: rahul.raj@hus.fi
Pihla Tommiska, MD, Specializing Physician
Email: pihla.tommiska@helsinki.fi
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
HUS lanseeraa uuden verkkomedian Husarin9.1.2025 09:22:27 EET | Tiedote
HUSin uusi verkkomedia Husari on julkaistu osoitteessa hus.fi/husari. Husari kertoo sairaanhoidon koskettavimmat tarinat ja kurkistaa myös kulissien taakse.
Incidensen av akut kranskärlssyndrom bland unga kvinnor minskar långsammare31.12.2024 10:33:02 EET | Pressmeddelande
I Finland har man inte lyckats minska incidensen av akut krankärlssyndrom bland unga och medelålders kvinnor. Bland äldre kvinnor och män minskade antalet fall årligen fram till 2010-talet, men nu har minskningen saktat av. Man har dock lyckats minska dödligheten i sjukdomen. Vikt bör dock fortfarande fästas vid att förebygga hjärt- och kärlsjukdomar.
Nuorten naisten sepelvaltimotautikohtausten ilmaantuvuuden lasku hidastunut31.12.2024 10:33:02 EET | Tiedote
Suomessa ei ole onnistuttu vähentämään sepelvaltimotautikohtausten ilmaantuvuutta nuorilla ja keski-ikäisillä naisilla. Ikääntyvillä naisilla ja miehillä kohtausten määrä väheni vuosittain 2010-luvulle saakka, mutta nyt lasku on hidastunut. Sairauteen kuolleisuutta on kuitenkin onnistuttu laskemaan. Edelleen tulee kiinnittää huomiota sydän- ja verisuonisairauksien ehkäisyyn.
Decrease in the incidence of acute myocardial ischemic syndrome in young women has slowed31.12.2024 10:33:02 EET | Press release
Finland has not succeeded in reducing the incidence of acute myocardial ischemic syndrome in young and middle-aged women. The number of cases among older women and men decreased every year until the 2010s, but this decline has now stagnated. However, there has been a reduction in the mortality rate. Attention should still be paid to the prevention of cardiovascular diseases.
HUS utökar användningen av eKonsultationer30.12.2024 10:56:44 EET | Pressmeddelande
HUS-sammanslutningens styrelse sammanträdde den 30 december 2024 för att behandla bland annat verkställigheten av sammanslutningens stämmas beslut av den 19 december 2024 samt en utökad användning av eKonsultationer mellan Nylands välfärdsområden, Helsingfors stad och HUS.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom